Pfizer says antiviral pill cuts rate of hospitalisation, death by 89 percent. Other Covid19 updates: 🇩🇪 Germany sees second straight case record 🇰🇷 South Korea buys 30M doses of Pfizer's vaccine for 2022 🇯🇵 Japan eases border rules More here:
A patient has a blood oxygen metering device to a finger in the Covid-19 section of University Clinical Centre hospital in Banja Luka, Bosnia, November 4, 2021. A trial of Pfizer Inc's experimental antiviral pill for Covid-19 was stopped early after the drug was shown to cut by 89 percent the chances of hospitalisation or death for adults at risk of developing severe disease, the company said.
The planned analysis of 1,219 patients in Pfizer's study looked at hospitalizations or deaths among people diagnosed with mild to moderate Covid-19 with at least one risk factor for developing severe disease, s uch as obesity or older age. While it's possible that the figures were pushed up by delayed testing and reporting following a regional holiday on Monday in some of the worst-affected areas, they underlined a steady rise in infections over recent weeks that has put Covid-19 firmly back in the headlines in Germany.South Korea has purchased an additional 30 million doses of Pfizer/BioNTech's Covid-19 vaccine for 2022, the Korea Disease Control and Prevention Agency said in a statement.
The government coronavirus task force said that collective immunity in the country stood at 48 percent. That was a slight increase from 46.8 percent a week ago, just before the start of a week-long workplace shutdown announced by President Vladimir Putin to try to slow the spread of the disease.The South American country has now registered a total of 608,671 deaths and 21,849,137 total confirmed cases, according to data released by the nation's Health Ministry.
The Republican governor also is continuing a program that gives private school vouchers to parents upset that their children's schools require masks or quarantines after being exposed to the virus.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer's Covid antiviral pill may cut severe illness by 89 percentThe drugmaker Pfizer said Friday that clinical trials of its experimental Covid-19 pill have been so successful in preventing people from becoming hospitalized
Leer más »
Pfizer's COVID-19 pill, Paxlovid, cuts hospitalizations, deaths by 89%'An extraordinary effect': Pfizer says its COVID-19 pill reduced the risk of hospitalization and death by 89% in high-risk patients
Leer más »
U.K. becomes first country to approve Merck's Covid-19 antiviral pillThe U.K.'s medicines regulator has approved the world's first pill designed to treat symptomatic Covid-19, the British government announced on Thursday.
Leer más »
As China faces its most widespread Covid outbreak since Wuhan, officials double down on zero CovidChina is scrambling to contain its most widespread Covid-19 outbreak since the first wave of infections that began in Wuhan in 2019.
Leer más »
Pfizer COVID-19 vaccine now available for kids ages 5 to 11: 5 things to knowAn 8-year-old receives his vaccine—and gets a hug from Dr. Bear—at a Washington hospital. What to know as the Pfizer COVID-19 vaccine is now available for kids ages 5 to 11:
Leer más »